Fagan Associates’s Cardinal Health CAH Stock Holding History

Fagan Associates’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$301K	Hold	1,266	–	–	0.04%	118
2026 Q1	$268K	Hold	1,266	–	–	0.04%	121
2025 Q4	$260K	Buy	+1,266	New	+$238K	0.03%	122
2025 Q3	–	Sell	-1,266	Closed	-$213K	–	135
2025 Q2	$213K	Buy	+1,266	New	+$188K	0.03%	122

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fagan Associates's CAH Position: Q2 2026 in Review

Fagan Associates held its Cardinal Health (CAH) position steady in Q2 2026 at 1,266 shares worth $301K. The position accounts for 0.04% of the portfolio, ranked #118.

Fagan Associates first reported a position in CAH in Q2 2025 and has held it in 4 quarters since. 1,239 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Fagan Associates held 1,266 shares of Cardinal Health worth $301K as of Q2 2026.
Fagan Associates left its Cardinal Health share count unchanged in Q2 2026.
Cardinal Health made up 0.04% of Fagan Associates's portfolio in Q2 2026, its #118 holding.
Fagan Associates first reported a position in Cardinal Health in Q2 2025 and has held it in 4 quarters since.
1,239 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Fagan Associates's 13F filing for Q2 2026, filed 4 Aug 2026.